Plans for Clinical Trials Post Brexit
Date: 01 November 2019
Plans for clinical trials in the event of a no-deal Brexit have been published by both the Health Research Authority and the Medicines and Healthcare products Regulatory Authority.
This advice includes: changes to sponsors/legal representatives, IMP certification and importation, amendments to the Research Ethics Committee, and transferring research data between countries.
- Summary:The HRA and MHRA have published plans for clinical trials in the event of a no-deal Brexit.